Clinical assessments for sexual health remain inconsistent for gynecologic cancer survivors, despite the high prevalence of treatment-related side effects. A study published in Supportive Care in Cancer on October 7, 2026, found that while clinicians recognize the importance of sexual health to quality of life, conversations are often reactive rather than routine. Researchers identified that time constraints, provider discomfort, and age-related assumptions frequently prevent these discussions from occurring during standard oncology visits.
Barriers to Routine Sexual Health Screening
Clinicians interviewed for the study, including oncologists, nurse practitioners, and physician assistants, cited a lack of time as the primary obstacle to addressing sexual health. These conversations are often deprioritized in favor of immediate symptom management, treatment decisions, and prognosis discussions.
The study revealed that clinicians often rely on patients to initiate the topic. This practice creates a significant gap in care, as many patients feel uncomfortable bringing up concerns independently. Researchers noted that providers frequently hold assumptions based on patient age, showing a greater tendency to discuss sexual health with younger patients while remaining silent with older demographics.
Disparities in Care Delivery
There is a clear divide in how sexual health is handled across the cancer care continuum. Data indicates that discussions are more likely to occur during survivorship or surveillance visits than during active treatment. reported that advanced practice providers (APPs) are often the ones to initiate these conversations, whereas many physicians view the assessment of sexual health as a task better suited for the APP role.
Research highlights that 57% of gynecologic cancer patients reported never discussing sexuality with their providers. While 34% of patients surveyed identified sexual health as important, the primary barrier to communication remained patient discomfort. These findings suggest that relying on patient initiative results in missed opportunities for care, as providers often use age as a proxy for sexual interest rather than assessing individual needs.
Strategies for Standardized Clinical Practice
To improve outcomes, the study authors suggest moving away from ad-hoc questioning toward standardized screening protocols. Integrating sexual health prompts directly into electronic health records (EHR) and clinical workflows could ensure that every patient is asked about their sexual health, regardless of age or relationship status.
Skill-based training is also identified as a necessary step to help clinicians address both the physical symptoms—such as dyspareunia and vaginal dryness—and the psychosocial aspects of intimacy and body image. By normalizing these assessments, oncology teams can better identify and treat the long-term changes that affect the quality of life for survivors of gynecologic cancer.
Questions Regarding Sexual Health in Oncology
Why do clinicians often wait for patients to bring up sexual health?
Many healthcare professionals report uncertainty regarding their professional roles and discomfort discussing the emotional aspects of intimacy. Evidence suggests that providers often rely on age as a signal to initiate these topics, which frequently leads to older patients being overlooked.
When is the most effective time to discuss sexual health during cancer care?
While many discussions currently take place during survivorship visits, research indicates that patients experience treatment-related changes throughout the entire cancer continuum. Standardized screening during various phases—including postoperative and surveillance visits—is recommended to catch concerns that patients might otherwise be reluctant to report.
What are the most common sexual health concerns reported by patients?
Patients most frequently report physical symptoms, including vaginal dryness, dyspareunia, and a loss of libido. However, these are often linked to broader challenges involving body image and sexual desire, which many clinicians feel less prepared to address compared to strictly physical side effects.
Historically, sexual health screening has been inconsistently applied, with studies showing that even when patients value these discussions, more than half of those in treatment never have the opportunity to address their concerns with their oncology team.
Related reading